Cubosomes as Potential Nanocarrier for Drug Delivery: A Comprehensive Review
Simran Deep Kaur, Gurdeep Singh, Gurpreet Singh, Keshav Singhal, Shubham Kant, Neena Bedi
Journal of Pharmaceutical Research International · pp. 118–135 · Published 14 Jun 2021
10.9734/jpri/2021/v33i31B31698Abstract
Lyotropic liquid crystalline cores are characterized as soft nanoparticles and referred as cubosomes. They are prepared to activate the natural self-assembly capability of lipids (e.g., monoolein or phytantriol) in water. Cubosomes are crystalline isotropic lipidic nanoparticles stabilized by Poloxamers such as F127, F108. It is made up of a network of two separate aqueous channels formed by a three-dimensional, non-intersecting lipid bilayer imposed over an indefinite periodic minimum surface of cubic symmetry. Cubosomes constitute unique features such as their special cubic structure which permits to incorporate highly lipophilic, hydrophilic, and amphiphilic drugs. Also, the lipids excipients used in the preparation of cubosomes such as monoolein, phytantriol are biodegradable and biocompatible so these cubic nanoparticles are referred as safe carrier for drug delivery. Cubic lipid nanoparticles have a highly stable cubic shape that allows for a slower rate of dissociation, improved drug retention, and site-specific drug delivery. The architecture of cubic particles provides suitability in the drug delivery as compared to other lipids-based drug delivery systems such as solid lipid nanoparticles (SLN), liposomes due to their drug expulsion to the surface of nanoparticles. Cubosomes with these loaded features/architectural composition led to an array of desired performance. Solvent evaporation, ultrasonication, hydrotrope, spray drying, melt dispersion emulsifying methods are used to prepare these carrier systems.
Cited by 32
Muhammad Khalil ur Rehman, Sibgha Batool, Sanghyun Woo · Scientific Reports · 2025
Navdeep Saini, Gurdeep Singh, Vridhi Sachdeva · Journal of Biologically Active Products from Nature · 2025
Sumedha Saxena, Amol Kumar, Rashmi Saxena Pal · Drug Metabolism and Bioanalysis Letters · 2025
Rajani THOUTREDDY, Koteswara Rao GSN, Narender MALOTHU · Journal of Research in Pharmacy · 2023
Fazila Zakaria, Siti Efliza Ashari, Intan Diana Mat Azmi · Journal of Drug Delivery Science and Technology · 2022
Wenjie Zhang, Reza Taheri-Ledari, Fatemeh Ganjali · RSC Advances · 2023
Saba Samari, Mohammad Reza Farahpour, Zohreh Ghazi Tabatabaei · Journal of Tissue Viability · 2025
· Advances in Biomembranes and Lipid Self-Assembly · 2022
Ahmad Salawi · Drug Design, Development and Therapy · 2026
Anshula Mehra, Abhay Tharmatt, Navdeep Saini · Recent Advances in Drug Delivery and Formulation · 2022
Showing 20 of 32 known citations — external sources report more than can currently be individually listed.
Related research
- Patient Preferences for the Mode and Frequency of Drug Formulations for Treating Adults with Psoriatic Arthritis: A Systematic Review Protocol — shares topic coverage
- In vitro Membranous activity of Biosynthesized Gold Nanoparticle from Aqueous Leave Extract of Nelsonia canescens — shares topic coverage
- Applications of Thin Films in Ophthalmology — shares topic coverage
- Synthesis and Characterization of Polymeric Nanoparticles Formed from Cowry Shells and Acacia Gum Extracts — shares topic coverage
- Improving the Slow Release System Using Chitosan-Alginate Nanoparticles with Various Methods for Curcumin — shares topic coverage
Article metrics
Real usage data collected on this platform.
1
Page views
0
PDF downloads
0
Outbound clicks
32
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.